DEA Regulatory Status

Regulatory Status of Cannabinoids

Purisys constantly works with global regulatory agencies on the subject of regulatory status of our ingredients. This includes work with the United States Drug Enforcement Agency (DEA) on descheduling of cannabinoids. The descheduling process will ease the regulatory compliance activities for companies developing pharmaceutical and consumer products with Purisys ingredients. Descheduling affects quotas, aggregates, secure vault storage and more. This also means our customers will no longer need DEA registrations to work with these materials. Please check back often as we expect additional compounds will become descheduled in the near future.

To date, the following Purisys compounds we have definitively determined are not controlled by the DEA when they have less than 0.3% THC.

Find Out More

Dibromo-Cannabidiol
D-9 Tetrahydrocannabivarinic acid (THCVA)
Cannabidiol Quinone
Cannabigerol (CBG)
4.6-Dibromo-olivetol
Cannabidiol-mono-valinate-mono-hemisuccinate
Cannabidiol-C4 (CBDB)
(+) - Cannabidiol
9-Tetrahydrocannabinolic Acid (THCBA)
Tetrahydrocannabinol-C4 (THCB)
9-Tetrahydrocannabinolic Acid-C4 (THCBA)
Cannabidiolic Acid C-4 (CBDBA)
Cannabinol-C4 3-Butylcannabinol (CBNB)
Cannabinolic Acid-C4 3-Butylcannabinolic acid (CBNBA)
Cannabigerol-C4 (CBGB)
Cannabigerolic Acid-C4 (CBGBA)
Cannabichromene-C4 (CBCB)
Cannabichromevarinic Acid-C4 (CBCBA)
Cannabicyclol-C4 (CBLB)
Cannabicyclolic Acid-C4 (CBLBA)